219 related articles for article (PubMed ID: 11253137)
21. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
[TBL] [Abstract][Full Text] [Related]
22. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
Nahum A; Hirsch K; Danilenko M; Watts CK; Prall OW; Levy J; Sharoni Y
Oncogene; 2001 Jun; 20(26):3428-36. PubMed ID: 11423993
[TBL] [Abstract][Full Text] [Related]
23. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas.
Glaessl A; Bosserhoff AK; Buettner R; Hohenleutner U; Landthaler M; Stolz W
Arch Dermatol Res; 1999; 291(2-3):81-7. PubMed ID: 10195394
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclins and cdks throughout murine carcinogenesis.
Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors.
Schmidt BA; Rose A; Steinhoff C; Strohmeyer T; Hartmann M; Ackermann R
Cancer Res; 2001 May; 61(10):4214-21. PubMed ID: 11358847
[TBL] [Abstract][Full Text] [Related]
26. Moesin and CD44 expression in cutaneous melanocytic tumours.
Ichikawa T; Masumoto J; Kaneko M; Saida T; Sagara J; Taniguchi S
Br J Dermatol; 1998 May; 138(5):763-8. PubMed ID: 9666819
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in human cutaneous malignant melanoma.
Trotter MJ; Tang L; Tron VA
J Cutan Pathol; 1997 May; 24(5):265-71. PubMed ID: 9194578
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms.
Zhang SY; Liu SC; Goodrow T; Morris R; Klein-Szanto AJ
Mol Carcinog; 1997 Mar; 18(3):142-52. PubMed ID: 9115584
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of G1 cyclins and cyclin-dependent kinase inhibitors in normal and transformed melanocytes.
Mouriaux F; Casagrande F; Pillaire MJ; Manenti S; Malecaze F; Darbon JM
Invest Ophthalmol Vis Sci; 1998 May; 39(6):876-84. PubMed ID: 9579467
[TBL] [Abstract][Full Text] [Related]
30. High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas.
Bales ES; Dietrich C; Bandyopadhyay D; Schwahn DJ; Xu W; Didenko V; Leiss P; Conrad N; Pereira-Smith O; Orengo I; Medrano EE
J Invest Dermatol; 1999 Dec; 113(6):1039-46. PubMed ID: 10594749
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
Coppock DL; Buffolino P; Kopman C; Nathanson L
Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
[TBL] [Abstract][Full Text] [Related]
32. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
33. Wnt ligand expression in malignant melanoma: pilot study indicating correlation with histopathological features.
Pham K; Milovanovic T; Barr RJ; Truong T; Holcombe RF
Mol Pathol; 2003 Oct; 56(5):280-5. PubMed ID: 14514922
[TBL] [Abstract][Full Text] [Related]
34. The role of cyclins and cyclin dependent kinases in development and progression of hepatitis C virus-genotype 4-associated hepatitis and hepatocellular carcinoma.
Bahnassy AA; Zekri AR; Loutfy SA; Mohamed WS; Moneim AA; Salem SE; Sheta MM; Omar A; Al-Zawahry H
Exp Mol Pathol; 2011 Oct; 91(2):643-52. PubMed ID: 21801719
[TBL] [Abstract][Full Text] [Related]
35. D-type cyclins and G1 progression during liver development in the rat.
Boylan JM; Gruppuso PA
Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
[TBL] [Abstract][Full Text] [Related]
37. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
Pisacane AM; Risio M
Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
[TBL] [Abstract][Full Text] [Related]
38. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
[TBL] [Abstract][Full Text] [Related]
39. Cyclin and cyclin-dependent kinase expression in human astrocytoma cell lines.
Dirks PB; Hubbard SL; Murakami M; Rutka JT
J Neuropathol Exp Neurol; 1997 Mar; 56(3):291-300. PubMed ID: 9056543
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
